Choline and cystine deficient diets in animal models with hepatocellular injury: Evaluation of oxidative stress and expression of RAGE, TNF-α, and IL-1β

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Santos, Juliana Célia F ^a   De Araújo, Orlando R P ^a   Valentim, Iara B ^b   De Andrade, Kívia Queiroz ^a   Moura, Fabiana Andréa ^a   Smaniotto, Salete ^a   Dos Santos, John Marques ^a   Gasparotto, Juciano ^c   Gelain, Daniel P ^c   Goulart, Marília O F ^a,d  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^b Institutio Federal de Educacao Ciencia Tecnologia Alagoas Brazil   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANIMALS; CYSTINES;

ANTIOXIDANT ENZYME; HEPATIC INJURY; HEPATIC STEATOSIS; HEPATOCELLULAR; LIPID PEROXIDATION; OXIDATIVE STRESS BIOMARKERS; REACTIVE SPECIES; THIOBARBITURIC ACID;

OXIDATIVE STRESS;

ADVANCED GLYCATION END PRODUCT RECEPTOR; CATALASE; CHOLINE; CYSTINE; INTERLEUKIN 1BETA; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; AGER PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FATTY LIVER; INFLAMMATION; LIPID PEROXIDATION; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; ANIMAL; BODY WEIGHT; DEFICIENCY; DIET; DISEASE MODEL; LIVER; METABOLISM; NONALCOHOLIC FATTY LIVER; PATHOLOGY; PROTEIN CARBONYLATION; WISTAR RAT;

ANIMALIA; RATTUS NORVEGICUS;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; BODY WEIGHT; CATALASE; CHOLINE; CYSTINE; DIET; DISEASE MODELS, ANIMAL; INTERLEUKIN-1BETA; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84935006835     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/121925     Document Type: Article

References (67)

1. J. D. Browning and J. D. Horton, "Molecular mediators of hepatic steatosis and liver injury, " The Journal of Clinical Investigation, vol. 114, no. 2, pp. 147-152, 2004.
2. Q.M.Anstee andR.D.Goldin, "Mousemodels in non-alcoholic fatty liver disease and steatohepatitis research, " International Journal of Experimental Pathology, vol. 87, no. 1, pp. 1-16, 2006.
3. N. Chalasani, Z. Younossi, J. E. Lavine et al., "The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, AmericanCollege of Gastroenterology, and the American GastroenterologicalAssociation, " Hepatology, vol. 55, no. 6, pp. 2005-2023, 2012.
4. J. C. D. F. Santos, I. B. Valentim, O. R. P. de Araújo, T. D. R. Ataide, and M. O. F. Goulart, "Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products, " International Journal of Molecular Sciences, vol. 14, no. 10, pp. 19846-19866, 2013.
5. I. Zamin Jr., A. A. de Mattos, A. Z. de Mattos, E. Migon, E. Soares, and M. L. S. Perry, "Modelo experimental de esteatohepatite não-alcoólica com dieta deficiente em metionina e colina, " Arquivos de Gastroenterologia, vol. 46, no. 1, pp. 69-74, 2009.
6. A. Koteish and A. Mae Diehl, "Animal models of steatohepatitis, " Best Practice & Research Clinical Gastroenterology, vol. 16, pp. 679-690, 2002.
7. D. R. Labrecque, Z. Abbas, V. Isakov, andM. Lizarzabal, "World gastroenterology organisation global guidelines nonalcoholic fatty liver disease and nonalcoholic steatohepatitis diagnostic strategy forNASH, " Journal of Clinical Gastroenterology, vol. 48, no. 6, pp. 467-473, 2014.
8. P. Starkel and I. A. Leclercq, "Animal models for the study of hepatic fibrosis, " Best Practice and Research: Clinical Gastroenterology, vol. 25, no. 2, pp. 319-333, 2011.
9. S. E. Hankinson, W. C. Willett, J. E. Manson et al., "Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women, " Journal of the National Cancer Institute, vol. 87, no. 17, pp. 1297-1302, 1995.
10. H. Jaeschke and A. Ramachandran, "Reactive oxygen species in the normal and acutely injured liver, " Journal of Hepatology, vol. 55, no. 1, pp. 227-228, 2011.
11. G. H. Koek, P. R. Liedorp, and A. Bast, "The role of oxidative stress in non-alcoholic steatohepatitis, " Clinica Chimica Acta, vol. 412, no. 15-16, pp. 1297-1305, 2011.
12. E. L. M.Guimarães, C. Empsen, A.Geerts, and L. A. vanGrunsven, "Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells, " Journal of Hepatology, vol. 52, no. 3, pp. 389-397, 2010.
13. M. Trauner, M. Arrese, andM.Wagner, "Fatty liver andlipotoxicity, " Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, vol. 1801, no. 3, pp. 299-310, 2010.
14. M. Brownlee, "Biochemistry and molecular cell biology of diabetic complications, " Nature, vol. 414, no. 6865, pp. 813-820, 2001.
15. P. J.Thornalley, S. Battah, N.Ahmed et al., "Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry, " Biochemical Journal, vol. 375, no. 3, pp. 581-592, 2003.
16. J. H. Barbosa, S. L. Oliveira, and L. T. Seara, "O papel dos produtos finais da glicação avançada (AGEs) no desencadeamento das complicações vasculares do diabetes, " Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 52, no. 6, pp. 940-950, 2008.
17. Y. Kimura, H. Hyogo, S.-I. Yamagishi et al., "Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH, " Journal of Gastroenterology, vol. 45, no. 7, pp. 750-757, 2010.
18. S.-I. Yamagishi, T. Matsui, K. Nakamura et al., "Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species, " Ophthalmic Research, vol. 40, no. 1, pp. 10-15, 2007.
19. P. G. Reeves, "Components of the AIN-93 diets as improvements in the AIN-76A diet, " Journal of Nutrition, vol. 127, no. 5, supplement, pp. 838S-841S, 1997, Proceedings of the Symposium "Animal Diets forNutritional and Toxicological Research".
20. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, "Protein measurement with the Folin phenol reagent, " The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265-275, 1951.
21. H. H. Draper andM. Hadley, "Malondialdehyde determination as index of lipid peroxidation, "Methods in Enzymology, vol. 186, pp. 421-431, 1990.
22. R. L. Levine, J. A. Williams, E. R. Stadtman, and E. Shacter, "Carbonyl assays for determination of oxidatively modified proteins, " inMethods in Enzymology, vol. 233, pp. 346-357, 1994.
23. L. N. Paton, T. J. Mocatta, A. M. Richards, and C. C. Winterbourn, "Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction, " Free Radical Biology and Medicine, vol. 48, no. 2, pp. 223-229, 2010.
24. H.Aebi, "Catalase in vitro, "Methods in Enzymology, vol. 105, pp. 121-126, 1984.
25. H. P.Misra and I. Fridovich, "Therole of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase, " The Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170-3175, 1972.
26. G. L. Ellman, "Tissue sulfhydryl groups, " Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70-77, 1959.
27. G.Kanuri and I. Bergheim, "In vitro and in vivomodels of nonalcoholic fatty liver disease (NAFLD), " International Journal of Molecular Sciences, vol. 14, no. 6, pp. 11963-11980, 2013.
28. M. B. Glier, T. J. Green, and A. M. Devlin, "Methyl nutrients, DNA methylation, and cardiovascular disease, " Molecular Nutrition and Food Research, vol. 58, no. 1, pp. 172-182, 2014.
29. A. J. Barak, H. C. Beckenhauer, M. Junnila, and D. J. Tuma, "Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration, " Alcoholism: Clinical and Experimental Research, vol. 17, no. 3, pp. 552-555, 1993.
30. K. D. Corbin and S. H. Zeisel, "Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression, " Current Opinion in Gastroenterology, vol. 28, no. 2, pp. 159-165, 2012.
31. G.Petrosillo, P.Portincasa, I. Grattagliano et al., "Mitochondrial dysfunction in rat with nonalcoholic fatty liver. Involvement of complex I, reactive oxygen species and cardiolipin, " Biochimica et Biophysica Acta, vol. 1767, no. 10, pp. 1260-1267, 2007.
32. J. J.Maher, "New insights from rodent models of fatty liver disease, " Antioxidants&Redox Signaling, vol. 15, no. 2, pp. 535-550, 2011.
33. R.Veteläinen, A. vanVliet, and T. M. vanGulik, "Essential pathogenic andmetabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model, " Journal of Gastroenterology and Hepatology, vol. 22, no. 9, pp. 1526-1533, 2007.
34. J. F. Santos, M. S. Amaral, S. L. Oliveira et al., "Dietary intake of AIN-93 standard diet induces fatty liver with altered hepatic fatty acid profile in Wistar rats, " Nutricíon Hospitalaria, vol. 31, no. 5, pp. 2140-2146, 2015.
35. A. L. de Melo Lucena, S. L. de Oliveira, T. da Roçha Ataide et al., "High-fat diet based on trienantin has no adverse metabolic effects in rats, " European Journal of Lipid Science and Technology, vol. 112, no. 2, pp. 166-172, 2010.
36. T. D. R. Ataíde, S. L. de Oliveira, F. M. da Silva, L. G. C. V. Filha, M. C.D. N. Tavares, andA. E.G. Sant'Ana, "Toxicological analysis of the chronic consumption of diheptanoin and triheptanoin in rats, " International Journal of Food Science & Technology, vol. 44, no. 3, pp. 484-492, 2009.
37. M. A. F. da Silva, T. R. Ataide, S. L. de Oliveira et al., "Efeito hepatoprotetor do consumo crônico de dieptanoína e trieptanoína contra a esteatose em ratos, " Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 52, no. 7, pp. 1145-1155, 2008.
38. M. L. Urso and P. M. Clarkson, "Oxidative stress, exercise, and antioxidant supplementation, " Toxicology, vol. 189, no. 1-2, pp. 41-54, 2003.
39. J. Guo, K. Prokai-Tatrai, V. Nguyen, N. Rauniyar, B. Ughy, and L. Prokai, "Protein targets for carbonylation by 4-hydroxy-2-nonenal in rat liver mitochondria, " Journal of Proteomics, vol. 74, no. 11, pp. 2370-2379, 2011.
40. M. A. Baraibar, R. Ladouce, and B. Friguet, "Proteomic quantification and identification of carbonylated proteins upon oxidative stress and during cellular aging, " Journal of Proteomics, vol. 92, pp. 63-70, 2013.
41. K.Hensley, Y.Kotake, H. Sang et al., "Dietary choline restriction causes complex I dysfunction and increasedH2O2 generation in liver mitochondria, " Carcinogenesis, vol. 21, no. 5, pp. 983-989, 2000.
42. C. P. Day and O. F. W. James, "Steatohepatitis: a tale of two 'hits'?" Gastroenterology, vol. 114, no. 4, pp. 842-845, 1998.
43. H. Bakala, M. Hamelin, J. Mary, C. Borot-Laloi, and B. Friguet, "Catalase, a target of glycation damage in rat liver mitochondria with aging, " Biochimica et Biophysica Acta, vol. 1822, no. 10, pp. 1527-1534, 2012.
44. G. Savoini, A. Agazzi, G. Invernizzi, D. Cattaneo, L. Pinotti, and A. Baldi, "Polyunsaturated fatty acids and choline in dairy goats nutrition: production and health benefits, " Small Ruminant Research, vol. 88, no. 2-3, pp. 135-144, 2010.
45. M. Cave, I. Deaciuc, C.Mendez, Z. Song, S. Joshi-Barve, and C. McClain, "Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition, " Journal of Nutritional Biochemistry, vol. 18, no. 3, pp. 184-195, 2007.
46. R. Lorenzi, M. E. Andrades, R. C. Bortolin, R. Nagai, F. Dal-Pizzol, and J. C. F. Moreira, "Oxidative damage in the liver of rats treated with glycolaldehyde, " International Journal of Toxicology, vol. 30, no. 2, pp. 253-258, 2011.
47. R. Ross, "Atherosclerosis - an inflammatory disease, " The New England Journal of Medicine, vol. 340, no. 2, pp. 115-126, 1999.
48. M. Dessì, A. Noce, P. Bertucci et al., "Atherosclerosis, dyslipidemia, and inflammation: the significant role of polyunsaturated fatty acids, " ISRN Inflammation, vol. 2013, Article ID 191823, 13 pages, 2013.
49. A. Tuttolomondo, D. Di Raimondo, R. Pecoraro, V. Arnao, A. Pinto, and G. Licata, "Atherosclerosis as an inflammatory disease, " Current Pharmaceutical Design, vol. 18, no. 28, pp. 4266-4288, 2012.
50. H. Yoshida and R. Kisugi, "Mechanisms of LDL oxidation, " Clinica Chimica Acta, vol. 411, no. 23-24, pp. 1875-1882, 2010.
51. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, "Oxidative stress, inflammation, and cancer: how are they linked?" Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1603-1616, 2010.
52. C.R.Boland, M. G. Luciani, C. Gasche, andA. Goel, "Infection, inflammation, and gastrointestinal cancer, " Gut, vol. 54, no. 9, pp. 1321-1331, 2005.
53. N. Yoshida, "Inflammation and oxidative stress in gastroesophageal reflux disease, " Journal of Clinical Biochemistry and Nutrition, vol. 40, no. 1, pp. 13-23, 2007.
54. J. Zhou, M. Febbraio, T. Wada et al., "Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPAR in promoting steatosis, " Gastroenterology, vol. 134, no. 2, pp. 556-567, 2008.
55. K. Yamaguchi, L. Yang, S. McCall et al., "Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, " Hepatology, vol. 45, no. 6, pp. 1366-1374, 2007.
56. D. P. Gelain, M. A. de Bittencourt Pasquali, F. F. Caregnato, and J. C. F. Moreira, "Vitamin A (retinol) up-regulates the receptor for advanced glycation endproducts (RAGE) through p38 and Akt oxidant-dependent activation, " Toxicology, vol. 289, no. 1, pp. 38-44, 2011.
57. S. Olteanu, M.Kandel-Kfir, A. Shaish et al., "Lack of interleukin-1 in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice, " Digestive and Liver Disease, vol. 46, no. 5, pp. 433-439, 2014.
58. L. Vonghia, P. Michielsen, and S. Francque, "Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis, " International Journal ofMolecular Sciences, vol. 14, no. 10, pp. 19867-19890, 2013.
59. A. P. Rolo, J. S. Teodoro, and C.M. Palmeira, "Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis, " Free Radical Biology and Medicine, vol. 52, no. 1, pp. 59-69, 2012.
60. K. Miura, Y. Kodama, S. Inokuchi et al., "Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1 in mice, " Gastroenterology, vol. 139, no. 1, pp. 323-334, 2010.
61. K. H. J. Gaens, P. M. G.Niessen, S. S. Rensen et al., "Endogenous formation of N-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis, " Journal of Hepatology, vol. 56, no. 3, pp. 647-655, 2012.
62. C. Leung, C. B. Herath, Z. Jia et al., "Dietary glycotoxins exacerbate progression of experimental fatty liver disease, " Journal of Hepatology, vol. 60, no. 4, pp. 832-838, 2014.
63. G. P. Sims, D. C. Rowe, S. T.Rietdijk, R. Herbst, and A. J. Coyle, "HMGB1 and RAGE in inflammation and cancer, " Annual Review of Immunology, vol. 28, pp. 367-388, 2010.
64. A. Riehl, J. Németh, P. Angel, and J. Hess, "The receptor RAGE: bridging inflammation and cancer, " Cell Communication and Signaling, vol. 7, article 12, 2009.
65. T. Pusterla, J. Nèmeth, I. Stein et al., "Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice, " Hepatology, vol. 58, no. 1, pp. 363-373, 2013.
66. R. Ito, Y. Ishii, S. Wakiyama et al., "Prognostic significance of receptor for advanced glycation end products expression in hepatocellular carcinoma after hepatectomy, " Journal of Surgical Research, vol. 192, no. 2, pp. 503-508, 2014.
67. M. Dougan and G. Dranoff, "Inciting inflammation: the RAGE about tumor promotion, " Journal of Experimental Medicine, vol. 205, no. 2, pp. 267-270, 2008.